메뉴 건너뛰기
Inflammatory Bowel Diseases
Volumn 14, Issue 5, 2008, Pages 725-727
Recombinant human epidermal growth factor enhances wound healing of pyoderma gangrenosum in a patient with ulcerative colitis
Author keywords

[No Author keywords available]
Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; EASYEF; HYDROCORTISONE; MESALAZINE; PREDNISOLONE; RECOMBINANT EPIDERMAL GROWTH FACTOR; STEROID;
EID: 44349117349     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20327     Document Type: Letter
Times cited : (7)
References (8)
  • 1
    • 22144438677 scopus 로고    scopus 로고
    • Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients
    • Reichrath J, Bens G, Bonowitz A, et al. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. Am Acad Dermatol. 2005;53:273-283.
    • (2005) Am Acad Dermatol , vol.53 , pp. 273-283
    • Reichrath, J.1    Bens, G.2    Bonowitz, A.3
  • 2
    • 0032554260 scopus 로고    scopus 로고
    • Pyoderma gangrenosum
    • Callen JP. Pyoderma gangrenosum. Lancet. 1998;351;581-585.
    • (1998) Lancet , vol.351 , pp. 581-585
    • Callen, J.P.1
  • 3
    • 0031799222 scopus 로고    scopus 로고
    • Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine
    • Futami H, Kodaira M, Furuta T, et al. Pyoderma gangrenosum complicating ulcerative colitis: successful treatment with methylprednisolone pulse therapy and cyclosporine. J Gastroenterol. 1998;33:408-411.
    • (1998) J Gastroenterol , vol.33 , pp. 408-411
    • Futami, H.1    Kodaira, M.2    Furuta, T.3
  • 4
    • 0033971605 scopus 로고    scopus 로고
    • Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions
    • Bennett ML, Jackson JM, Jorizzo JL, et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine. 2000;79:37-46.
    • (2000) Medicine , vol.79 , pp. 37-46
    • Bennett, M.L.1    Jackson, J.M.2    Jorizzo, J.L.3
  • 5
    • 0031581493 scopus 로고    scopus 로고
    • Pyoderma gangrenosum and its treatment
    • Powell RJ, Holbrook MR, Stevens A. Pyoderma gangrenosum and its treatment. Lancet. 1997;350;1720-1721.
    • (1997) Lancet , vol.350 , pp. 1720-1721
    • Powell, R.J.1    Holbrook, M.R.2    Stevens, A.3
  • 6
    • 0042236643 scopus 로고    scopus 로고
    • Optimal treatment of pyoderma gangrenosum
    • Gettler S, Rothe M, Grin C, et al. Optimal treatment of pyoderma gangrenosum. Am J Clin Dermatol. 2003;4:597-608.
    • (2003) Am J Clin Dermatol , vol.4 , pp. 597-608
    • Gettler, S.1    Rothe, M.2    Grin, C.3
  • 7
    • 0041571851 scopus 로고    scopus 로고
    • Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease
    • Regueiro M, Valentine J, Plevy S, et al. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol. 2003;98:1821-1826.
    • (2003) Am J Gastroenterol , vol.98 , pp. 1821-1826
    • Regueiro, M.1    Valentine, J.2    Plevy, S.3
  • 8
    • 33645408337 scopus 로고    scopus 로고
    • Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers
    • Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers. Ann Plast Surg. 2006;56:394-398.
    • (2006) Ann Plast Surg , vol.56 , pp. 394-398
    • Hong, J.P.1    Jung, H.D.2    Kim, Y.W.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.